ProfileGDS4718 / 218394_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 62% 78% 57% 55% 53% 57% 64% 59% 57% 59% 58% 52% 54% 52% 57% 61% 52% 65% 60% 55% 58% 55% 60% 51% 58% 62% 60% 62% 52% 63% 56% 67% 56% 65% 53% 58% 64% 68% 76% 64% 51% 67% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9588657
GSM549102patient 115, normal, homogenized [OPG study]6.2683762
GSM549104patient 119, normal, homogenized [OPG study]7.7467278
GSM549108patient 138, normal, homogenized [OPG study]5.9558357
GSM549119patient 077, normal, homogenized [OPG study]5.8299755
GSM549133patient 032, cancer, homogenized [OPG study]5.6540953
GSM549139patient 042, cancer, homogenized [OPG study]5.8972357
GSM549099patient 107, normal, homogenized [OPG study]6.3847464
GSM549109patient 139, normal, homogenized [OPG study]6.0974359
GSM549110patient 046, normal, homogenized [OPG study]5.9011757
GSM549114patient 063, normal, homogenized [OPG study]6.0302759
GSM549122patient 082, normal, homogenized [OPG study]6.0437658
GSM549134patient 033, cancer, homogenized [OPG study]5.5919452
GSM549136patient 036, cancer, homogenized [OPG study]5.6947754
GSM549140patient 044, cancer, homogenized [OPG study]5.5820152
GSM549111patient 047, normal, homogenized [OPG study]5.9109357
GSM549113patient 057, normal, homogenized [OPG study]6.1370861
GSM549132patient 031, cancer, homogenized [OPG study]5.5951952
GSM549137patient 038, cancer, homogenized [OPG study]6.4943465
GSM549142patient 047, cancer, homogenized [OPG study]6.201260
GSM549100patient 110, normal, homogenized [OPG study]5.8241355
GSM549107patient 135, normal, homogenized [OPG study]5.9774358
GSM549115patient 068, normal, homogenized [OPG study]5.7956855
GSM549116patient 072, normal, homogenized [OPG study]6.1546860
GSM549120patient 078, normal, homogenized [OPG study]5.5693151
GSM549131patient 030, cancer, homogenized [OPG study]5.980158
GSM549118patient 074, normal, homogenized [OPG study]6.2879462
GSM549129patient 027, cancer, homogenized [OPG study]6.1692860
GSM549123patient 088, normal, homogenized [OPG study]6.2787262
GSM549124patient 006, cancer, homogenized [OPG study]5.6692952
GSM549126patient 015, cancer, homogenized [OPG study]6.3322963
GSM549128patient 025, cancer, homogenized [OPG study]5.8556556
GSM549103patient 117, normal, homogenized [OPG study]6.5737467
GSM549117patient 073, normal, homogenized [OPG study]5.8288656
GSM549138patient 041, cancer, homogenized [OPG study]6.4701465
GSM549141patient 045, cancer, homogenized [OPG study]5.6636353
GSM549130patient 028, cancer, homogenized [OPG study]5.9905658
GSM549101patient 111, normal, homogenized [OPG study]6.4234864
GSM549105patient 128, normal, homogenized [OPG study]6.6917768
GSM549106patient 134, normal, homogenized [OPG study]7.5720976
GSM549112patient 048, normal, homogenized [OPG study]6.416764
GSM549125patient 011, cancer, homogenized [OPG study]5.5542951
GSM549127patient 024, cancer, homogenized [OPG study]6.6867667
GSM549135patient 035, cancer, homogenized [OPG study]6.2504762